| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.785 | 0.002 | 0.785 | Plasminogen activator inhibitor antagonist | 0.054 0.028 CID_19100 0.328 0.004 CID_154699531 | ||
| 0.782 | 0.018 | 0.858 | Antiinflammatory | 0.807 0.014 CID_19100 0.858 0.009 CID_154699531 | CID_154699531 | |
| 0.734 | 0.004 | 0.734 | Immunosuppressant | 0.72 0.005 CID_19100 0.701 0.005 CID_154699531 | ||
| 0.698 | 0.005 | 0.698 | Platelet antagonist | 0.347 0.039 CID_19100 0.664 0.005 CID_154699531 | ||
| 0.65 | 0.01 | 0.65 | Vasodilator, peripheral | 0.62 0.014 CID_19100 0.543 0.022 CID_154699531 | ||
| 0.603 | 0.004 | 0.633 | Anesthetic general | 0.357 0.023 CID_19100 0.633 0.004 CID_154699531 | CID_154699531 | |
| 0.596 | 0.019 | 0.78 | Cholesterol antagonist | 0.634 0.014 CID_19100 0.78 0.004 CID_154699531 | CID_154699531 | |
| 0.558 | 0.013 | 0.582 | Caspase 3 stimulant | 0.368 0.054 CID_19100 0.582 0.011 CID_154699531 | CID_154699531 | |
| 0.553 | 0.017 | 0.66 | Spasmolytic | 0.444 0.032 CID_19100 0.66 0.008 CID_154699531 | CID_154699531 | |
| 0.533 | 0.005 | 0.533 | Interleukin 2 agonist | 0.481 0.01 CID_19100 0.531 0.005 CID_154699531 | ||
| 0.551 | 0.028 | 0.751 | Antibacterial | 0.479 0.047 CID_19100 0.751 0.005 CID_154699531 | CID_154699531 | |
| 0.476 | 0.007 | 0.533 | Interferon gamma antagonist | 0.376 0.012 CID_19100 0.533 0.004 CID_154699531 | CID_154699531 | |
| 0.497 | 0.029 | 0.765 | Antithrombotic | 0.478 0.032 CID_19100 0.765 0.005 CID_154699531 | CID_154699531 | |
| 0.519 | 0.053 | 0.519 | Caspase 9 stimulant | 0.47 0.073 CID_19100 0.51 0.056 CID_154699531 | ||
| 0.497 | 0.045 | 0.771 | Transcription factor NF kappa B inhibitor | 0.374 0.07 CID_19100 0.771 0.015 CID_154699531 | CID_154699531 | |
| 0.467 | 0.015 | 0.467 | Hypolipemic | 0.342 0.037 CID_19100 0.437 0.019 CID_154699531 | ||
| 0.517 | 0.069 | 0.697 | Apoptosis agonist | 0.425 0.102 CID_19100 0.697 0.031 CID_154699531 | CID_154699531 | |
| 0.43 | 0.004 | 0.43 | Vanilloid agonist | 0.094 0.041 CID_19100 0.179 0.008 CID_154699531 | ||
| 0.449 | 0.031 | 0.567 | Immunomodulator | 0.401 0.043 CID_19100 0.567 0.015 CID_154699531 | CID_154699531 | |
| 0.423 | 0.008 | 0.495 | Alpha-N-acetylglucosaminidase inhibitor | 0.415 0.008 CID_19100 0.495 0.005 CID_154699531 | CID_154699531 | |
| 0.43 | 0.015 | 0.55 | Interleukin agonist | 0.365 0.025 CID_19100 0.55 0.006 CID_154699531 | CID_154699531 | |
| 0.425 | 0.011 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.361 0.033 CID_19100 0.331 0.053 CID_154699531 | ||
| 0.434 | 0.022 | 0.585 | Nitric oxide antagonist | 0.488 0.017 CID_19100 0.585 0.01 CID_154699531 | CID_154699531 | |
| 0.418 | 0.01 | 0.499 | Thrombolytic | 0.152 0.08 CID_19100 0.499 0.005 CID_154699531 | CID_154699531 | |
| 0.409 | 0.004 | 0.409 | Cholesterol synthesis inhibitor | 0.377 0.005 CID_19100 0.319 0.009 CID_154699531 | ||
| 0.431 | 0.027 | 0.552 | Vasodilator, coronary | 0.324 0.069 CID_19100 0.552 0.01 CID_154699531 | CID_154699531 | |
| 0.408 | 0.006 | 0.408 | Antipruritic | 0.294 0.015 CID_19100 0.205 0.045 CID_154699531 | ||
| 0.411 | 0.021 | 0.411 | Calcium channel activator | 0.352 0.049 CID_19100 | ||
| 0.376 | 0.014 | 0.471 | Melanin inhibitor | 0.261 0.027 CID_19100 0.471 0.008 CID_154699531 | CID_154699531 | |
| 0.433 | 0.074 | 0.806 | Cyclophilin D inhibitor | 0.601 0.027 CID_19100 0.806 0.006 CID_154699531 | CID_154699531 | |
| 0.38 | 0.024 | 0.38 | Transcription factor STAT inhibitor | 0.236 0.097 CID_19100 0.187 0.158 CID_154699531 | ||
| 0.419 | 0.076 | 0.419 | Analgesic | |||
| 0.358 | 0.018 | 0.475 | Platelet adhesion inhibitor | 0.267 0.044 CID_19100 0.475 0.006 CID_154699531 | CID_154699531 | |
| 0.361 | 0.023 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.369 0.022 CID_19100 0.339 0.025 CID_154699531 | CID_19100 | |
| 0.34 | 0.004 | 0.521 | ATPase inhibitor | 0.341 0.004 CID_19100 0.521 0.003 CID_154699531 | CID_154699531 | |
| 0.339 | 0.006 | 0.719 | Expectorant | 0.386 0.005 CID_19100 0.719 0.002 CID_154699531 | CID_154699531 | |
| 0.36 | 0.031 | 0.365 | Vasodilator | 0.29 0.051 CID_19100 0.365 0.029 CID_154699531 | CID_154699531 | |
| 0.334 | 0.01 | 0.334 | Anesthetic local | 0.149 0.049 CID_19100 | ||
| 0.374 | 0.057 | 0.574 | Immunostimulant | 0.339 0.067 CID_19100 0.574 0.02 CID_154699531 | CID_154699531 | |
| 0.322 | 0.005 | 0.68 | Cyclooxygenase 3 inhibitor | 0.169 0.034 CID_19100 0.68 0.002 CID_154699531 | CID_154699531 | |
| 0.328 | 0.012 | 0.328 | Neurotrophic factor enhancer | 0.3 0.018 CID_19100 0.304 0.017 CID_154699531 | ||
| 0.33 | 0.017 | 0.337 | Gastrin inhibitor | 0.337 0.014 CID_19100 0.263 0.065 CID_154699531 | CID_19100 | |
| 0.34 | 0.028 | 0.345 | 5 Hydroxytryptamine uptake stimulant | 0.345 0.027 CID_19100 | CID_19100 | |
| 0.307 | 0.005 | 0.307 | T cell inhibitor | 0.21 0.007 CID_19100 0.108 0.019 CID_154699531 | ||
| 0.303 | 0.004 | 0.415 | Photosensitizer | 0.168 0.022 CID_19100 0.415 0.003 CID_154699531 | CID_154699531 | |
| 0.312 | 0.017 | 0.312 | Phospholipase C inhibitor | 0.184 0.057 CID_19100 0.2 0.044 CID_154699531 | ||
| 0.308 | 0.027 | 0.516 | Hepatoprotectant | 0.473 0.008 CID_19100 0.516 0.006 CID_154699531 | CID_154699531 | |
| 0.283 | 0.004 | 0.288 | Vanilloid 1 agonist | 0.161 0.029 CID_19100 0.288 0.004 CID_154699531 | CID_154699531 | |
| 0.33 | 0.052 | 0.645 | Antioxidant | 0.209 0.107 CID_19100 0.645 0.008 CID_154699531 | CID_154699531 | |
| 0.294 | 0.018 | 0.426 | Protein kinase stimulant | 0.219 0.035 CID_19100 0.426 0.007 CID_154699531 | CID_154699531 | |
| 0.288 | 0.02 | 0.324 | NOS3 expression enhancer | 0.188 0.046 CID_19100 0.324 0.014 CID_154699531 | CID_154699531 | |
| 0.29 | 0.023 | 0.29 | Lipocortins synthesis antagonist | 0.271 0.027 CID_19100 0.187 0.066 CID_154699531 | ||
| 0.331 | 0.066 | 0.535 | Apoptosis antagonist | 0.293 0.09 CID_19100 0.535 0.016 CID_154699531 | CID_154699531 | |
| 0.261 | 0.003 | 0.261 | Purinergic P2Y12 antagonist | 0.212 0.004 CID_154699531 | ||
| 0.262 | 0.005 | 0.263 | Microtubule formation inhibitor | 0.243 0.01 CID_19100 0.263 0.005 CID_154699531 | CID_154699531 | |
| 0.247 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.24 0.008 CID_19100 0.189 0.044 CID_154699531 | ||
| 0.265 | 0.024 | 0.532 | Amylase inhibitor | 0.167 0.056 CID_19100 0.532 0.005 CID_154699531 | CID_154699531 | |
| 0.287 | 0.048 | 0.431 | DNA synthesis inhibitor | 0.318 0.038 CID_19100 0.431 0.018 CID_154699531 | CID_154699531 | |
| 0.267 | 0.037 | 0.5 | Non-steroidal antiinflammatory agent | 0.192 0.078 CID_19100 0.5 0.007 CID_154699531 | CID_154699531 | |
| 0.24 | 0.014 | 0.24 | Neurotrophic factor | 0.182 0.037 CID_19100 0.125 0.088 CID_154699531 | ||
| 0.24 | 0.015 | 0.395 | Antineoplastic antibiotic | 0.233 0.016 CID_19100 0.395 0.005 CID_154699531 | CID_154699531 | |
| 0.231 | 0.016 | 0.231 | GABA C receptor agonist | 0.225 0.016 CID_19100 | ||
| 0.213 | 0.004 | 0.213 | Glycine receptor agonist | 0.162 0.005 CID_19100 0.201 0.004 CID_154699531 | ||
| 0.215 | 0.01 | 0.339 | Mucolytic | 0.339 0.004 CID_19100 0.255 0.006 CID_154699531 | CID_19100 | |
| 0.212 | 0.009 | 0.212 | TRPA1 agonist | 0.105 0.078 CID_19100 0.188 0.013 CID_154699531 | ||
| 0.216 | 0.014 | 0.218 | CF transmembrane conductance regulator agonist | 0.218 0.014 CID_19100 0.152 0.073 CID_154699531 | CID_19100 | |
| 0.245 | 0.045 | 0.245 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.165 0.117 CID_19100 | ||
| 0.203 | 0.01 | 0.213 | Pregnane X receptor agonist | 0.213 0.008 CID_19100 | CID_19100 | |
| 0.222 | 0.029 | 0.222 | Heat shock protein 90 antagonist | |||
| 0.259 | 0.072 | 0.662 | Hypoglycemic | 0.383 0.03 CID_19100 0.662 0.005 CID_154699531 | CID_154699531 | |
| 0.2 | 0.014 | 0.209 | Adenylate cyclase stimulant | 0.209 0.01 CID_19100 0.133 0.096 CID_154699531 | CID_19100 | |
| 0.25 | 0.068 | 0.558 | Free radical scavenger | 0.558 0.011 CID_154699531 | CID_154699531 | |
| 0.263 | 0.083 | 0.267 | 5 Hydroxytryptamine release stimulant | 0.22 0.106 CID_19100 0.267 0.081 CID_154699531 | CID_154699531 | |
| 0.182 | 0.003 | 0.182 | Cholesterol esterase inhibitor | 0.056 0.022 CID_19100 0.063 0.015 CID_154699531 | ||
| 0.236 | 0.062 | 0.441 | Peptidyltransferase inhibitor | 0.255 0.047 CID_19100 0.441 0.005 CID_154699531 | CID_154699531 | |
| 0.181 | 0.008 | 0.181 | Prostaglandin EP2 antagonist | 0.148 0.01 CID_19100 | ||
| 0.184 | 0.012 | 0.184 | Opioid kappa receptor antagonist | 0.183 0.012 CID_19100 | ||
| 0.178 | 0.008 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.183 0.005 CID_19100 0.175 0.009 CID_154699531 | CID_19100 | |
| 0.199 | 0.03 | 0.435 | Cell wall synthesis inhibitor | 0.234 0.019 CID_19100 0.435 0.005 CID_154699531 | CID_154699531 | |
| 0.17 | 0.005 | 0.241 | Glycine receptor antagonist | 0.241 0.003 CID_19100 0.188 0.004 CID_154699531 | CID_19100 | |
| 0.168 | 0.004 | 0.168 | Glutamate (mGluR3) antagonist | 0.058 0.009 CID_19100 0.035 0.028 CID_154699531 | ||
| 0.246 | 0.082 | 0.312 | DNA damaging | 0.161 0.156 CID_19100 0.312 0.053 CID_154699531 | CID_154699531 | |
| 0.24 | 0.078 | 0.25 | Tyrosine 3 hydroxylase inhibitor | 0.25 0.068 CID_19100 | CID_19100 | |
| 0.233 | 0.073 | 0.359 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.123 CID_19100 0.359 0.024 CID_154699531 | CID_154699531 | |
| 0.164 | 0.005 | 0.164 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 CID_19100 0.164 0.005 CID_154699531 | ||
| 0.185 | 0.027 | 0.185 | Farnesoid X receptor antagonist | 0.169 0.035 CID_19100 | ||
| 0.161 | 0.005 | 0.161 | Opioid kappa receptor agonist | 0.129 0.007 CID_19100 0.046 0.027 CID_154699531 | ||
| 0.194 | 0.039 | 0.357 | Insulin secretagoues | 0.357 0.008 CID_154699531 | CID_154699531 | |
| 0.167 | 0.013 | 0.167 | CYP2A6 inhibitor | |||
| 0.173 | 0.02 | 0.234 | GABA C receptor antagonist | 0.234 0.008 CID_19100 | CID_19100 | |
| 0.164 | 0.012 | 0.18 | Anabolic | 0.18 0.007 CID_19100 0.097 0.067 CID_154699531 | CID_19100 | |
| 0.229 | 0.08 | 0.77 | Angiogenesis stimulant | 0.255 0.068 CID_19100 0.77 0.004 CID_154699531 | CID_154699531 | |
| 0.198 | 0.05 | 0.198 | Heat shock protein 90 alpha antagonist | |||
| 0.214 | 0.068 | 0.215 | Nitric-oxide synthase stimulant | 0.208 0.076 CID_19100 0.215 0.066 CID_154699531 | CID_154699531 | |
| 0.162 | 0.017 | 0.257 | Triose-phosphate isomerase inhibitor | 0.141 0.023 CID_19100 0.257 0.006 CID_154699531 | CID_154699531 | |
| 0.166 | 0.024 | 0.304 | UDP-glucose 4-epimerase inhibitor | 0.156 0.027 CID_19100 0.304 0.01 CID_154699531 | CID_154699531 | |
| 0.151 | 0.011 | 0.151 | Interleukin 5 antagonist | 0.119 0.024 CID_19100 0.113 0.029 CID_154699531 | ||
| 0.145 | 0.005 | 0.145 | Prostaglandin F2 alpha antagonist | 0.128 0.005 CID_19100 | ||
| 0.156 | 0.016 | 0.156 | Interleukin 2 antagonist | 0.107 0.071 CID_19100 | ||
| 0.172 | 0.034 | 0.172 | Interleukin 4 antagonist | 0.134 0.066 CID_19100 0.159 0.042 CID_154699531 | ||
| 0.143 | 0.005 | 0.143 | TRPM8 blocker | 0.043 0.021 CID_19100 | ||
| 0.144 | 0.007 | 0.264 | Protein 50S ribosomal subunit inhibitor | 0.123 0.009 CID_19100 0.264 0.004 CID_154699531 | CID_154699531 | |
| 0.132 | 0.005 | 0.132 | Heat shock protein 90 beta antagonist | 0.054 0.051 CID_19100 | ||
| 0.15 | 0.022 | 0.15 | Prolactin inhibitor | 0.098 0.057 CID_19100 | ||
| 0.15 | 0.023 | 0.15 | Transcription factor STAT6 inhibitor | |||
| 0.204 | 0.078 | 0.319 | Psychostimulant | 0.319 0.038 CID_19100 0.223 0.069 CID_154699531 | CID_19100 | |
| 0.131 | 0.006 | 0.131 | Purinergic P2Y antagonist | 0.04 0.036 CID_19100 0.116 0.008 CID_154699531 | ||
| 0.181 | 0.057 | 0.181 | Cytidine deaminase inhibitor | |||
| 0.132 | 0.009 | 0.132 | Opioid agonist | 0.053 0.037 CID_19100 | ||
| 0.134 | 0.012 | 0.144 | mTOR complex 2 inhibitor | 0.144 0.01 CID_19100 | CID_19100 | |
| 0.129 | 0.009 | 0.167 | Androgen agonist | 0.167 0.006 CID_19100 | CID_19100 | |
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.132 0.02 CID_19100 | ||
| 0.144 | 0.029 | 0.144 | Adenylate kinase inhibitor | 0.138 0.031 CID_19100 0.092 0.083 CID_154699531 | ||
| 0.127 | 0.013 | 0.139 | Na+ K+ transporting ATPase inhibitor | 0.136 0.009 CID_19100 0.139 0.008 CID_154699531 | CID_154699531 | |
| 0.127 | 0.014 | 0.127 | Bile acid receptor antagonist | 0.1 0.049 CID_19100 0.091 0.071 CID_154699531 | ||
| 0.187 | 0.074 | 0.194 | P-glycoprotein inhibitor | 0.194 0.068 CID_19100 0.166 0.094 CID_154699531 | CID_19100 | |
| 0.133 | 0.022 | 0.235 | Phosphofructokinase-1 inhibitor | 0.155 0.017 CID_19100 0.235 0.008 CID_154699531 | CID_154699531 | |
| 0.131 | 0.019 | 0.143 | mTOR complex 1 inhibitor | 0.143 0.013 CID_19100 | CID_19100 | |
| 0.139 | 0.03 | 0.16 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.132 0.033 CID_19100 0.16 0.024 CID_154699531 | CID_154699531 | |
| 0.139 | 0.029 | 0.139 | Opioid antagonist | 0.13 0.032 CID_19100 | ||
| 0.121 | 0.015 | 0.121 | Purinergic P2 antagonist | |||
| 0.124 | 0.021 | 0.124 | Analgesic, opioid | 0.102 0.03 CID_19100 | ||
| 0.217 | 0.114 | 0.262 | Transcription factor STAT3 inhibitor | 0.262 0.075 CID_19100 | CID_19100 | |
| 0.123 | 0.023 | 0.123 | Inducible nitric-oxide synthase inhibitor | |||
| 0.107 | 0.008 | 0.114 | Glutamate (mGluR6) antagonist | 0.114 0.006 CID_19100 0.062 0.06 CID_154699531 | CID_19100 | |
| 0.132 | 0.033 | 0.132 | HIV-1 integrase (Overall Integration) inhibitor | 0.094 0.061 CID_19100 | ||
| 0.125 | 0.026 | 0.182 | NADH dehydrogenase inhibitor | 0.12 0.028 CID_19100 0.182 0.012 CID_154699531 | CID_154699531 | |
| 0.1 | 0.002 | 0.1 | Glutamate (mGluR3) agonist | 0.054 0.004 CID_19100 0.054 0.004 CID_154699531 | ||
| 0.146 | 0.051 | 0.195 | DNA polymerase I inhibitor | 0.195 0.03 CID_19100 0.165 0.041 CID_154699531 | CID_19100 | |
| 0.125 | 0.031 | 0.145 | Androgen antagonist | 0.145 0.024 CID_19100 | CID_19100 | |
| 0.097 | 0.004 | 0.097 | ATP citrate lysase inhibitor | 0.048 0.008 CID_19100 0.03 0.025 CID_154699531 | ||
| 0.117 | 0.028 | 0.117 | Ornithine decarboxylase inhibitor | 0.098 0.047 CID_19100 0.092 0.053 CID_154699531 | ||
| 0.106 | 0.017 | 0.106 | Alcohol oxidase inhibitor | 0.101 0.018 CID_19100 | ||
| 0.107 | 0.019 | 0.123 | Carbamoyl phosphate synthetase inhibitor | 0.123 0.015 CID_19100 | CID_19100 | |
| 0.09 | 0.004 | 0.09 | Parathyroid hormone antagonist | 0.055 0.016 CID_19100 0.044 0.034 CID_154699531 | ||
| 0.134 | 0.049 | 0.134 | Cystathionine beta-synthase inhibitor | 0.123 0.056 CID_19100 0.11 0.066 CID_154699531 | ||
| 0.168 | 0.083 | 0.168 | Succinate dehydrogenase inhibitor | 0.166 0.086 CID_19100 | ||
| 0.217 | 0.133 | 0.218 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.14 CID_19100 0.218 0.131 CID_154699531 | CID_154699531 | |
| 0.094 | 0.01 | 0.107 | 5-Alpha-reductase inhibitor | 0.107 0.009 CID_19100 0.05 0.019 CID_154699531 | CID_19100 | |
| 0.276 | 0.193 | 0.344 | 5 Hydroxytryptamine release inhibitor | 0.284 0.184 CID_19100 0.344 0.12 CID_154699531 | CID_154699531 | |
| 0.126 | 0.044 | 0.126 | Estrogen antagonist | 0.105 0.086 CID_19100 | ||
| 0.143 | 0.065 | 0.143 | Calcium channel blocker | |||
| 0.082 | 0.004 | 0.082 | Prostaglandin D2 agonist | 0.078 0.004 CID_19100 | ||
| 0.104 | 0.026 | 0.118 | Interferon agonist | 0.1 0.028 CID_19100 0.118 0.018 CID_154699531 | CID_154699531 | |
| 0.102 | 0.026 | 0.102 | Estrogen receptor alpha antagonist | 0.079 0.05 CID_19100 | ||
| 0.085 | 0.011 | 0.085 | Lipocortins synthesis agonist | 0.084 0.011 CID_19100 0.08 0.013 CID_154699531 | ||
| 0.078 | 0.004 | 0.078 | HMG CoA reductase inhibitor | 0.053 0.006 CID_19100 0.047 0.009 CID_154699531 | ||
| 0.094 | 0.019 | 0.094 | MAP kinase kinase 7 inhibitor | 0.094 0.019 CID_19100 | ||
| 0.099 | 0.025 | 0.099 | Estrogen-related receptor beta agonist | 0.081 0.065 CID_19100 | ||
| 0.091 | 0.017 | 0.101 | Interferon inducer | 0.087 0.019 CID_19100 0.101 0.012 CID_154699531 | CID_154699531 | |
| 0.131 | 0.058 | 0.131 | Adenylate cyclase inhibitor | 0.105 0.08 CID_19100 | ||
| 0.081 | 0.008 | 0.081 | Ryanodine receptor antagonist | 0.063 0.029 CID_19100 | ||
| 0.079 | 0.008 | 0.079 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.088 | 0.019 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.083 0.021 CID_19100 | ||
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | |||
| 0.089 | 0.022 | 0.104 | Argininosuccinate synthase inhibitor | 0.104 0.018 CID_19100 | CID_19100 | |
| 0.182 | 0.115 | 0.197 | Aldehyde oxidase inhibitor | 0.197 0.106 CID_19100 | CID_19100 | |
| 0.07 | 0.004 | 0.07 | Prostacyclin agonist | 0.065 0.004 CID_19100 | ||
| 0.075 | 0.009 | 0.098 | Pregnane X receptor antagonist | 0.098 0.004 CID_19100 | CID_19100 | |
| 0.089 | 0.024 | 0.089 | Aromatase inhibitor | |||
| 0.09 | 0.026 | 0.09 | Vanilloid 4 agonist | 0.088 0.028 CID_19100 | ||
| 0.074 | 0.011 | 0.087 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_19100 0.087 0.007 CID_154699531 | CID_154699531 | |
| 0.111 | 0.048 | 0.111 | Creatine kinase inhibitor | 0.103 0.056 CID_19100 | ||
| 0.066 | 0.004 | 0.066 | Vitamin D receptor antagonist | 0.033 0.006 CID_19100 0.025 0.01 CID_154699531 | ||
| 0.19 | 0.128 | 0.19 | Superoxide dismutase inhibitor | |||
| 0.139 | 0.078 | 0.139 | Heat shock protein 70 antagonist | 0.131 0.116 CID_19100 0.137 0.088 CID_154699531 | ||
| 0.068 | 0.007 | 0.068 | Farnesoid X receptor agonist | 0.054 0.013 CID_19100 | ||
| 0.094 | 0.034 | 0.106 | Glutamate dehydrogenase inhibitor | 0.106 0.028 CID_19100 | CID_19100 | |
| 0.063 | 0.005 | 0.063 | Tubulin agonist | 0.062 0.005 CID_19100 0.035 0.022 CID_154699531 | ||
| 0.073 | 0.015 | 0.114 | Alpha-mannosidase inhibitor | 0.079 0.012 CID_19100 0.114 0.005 CID_154699531 | CID_154699531 | |
| 0.061 | 0.003 | 0.067 | Prostaglandin F2 alpha agonist | 0.067 0.003 CID_19100 | CID_19100 | |
| 0.075 | 0.018 | 0.128 | Glucosylceramidase inhibitor | 0.128 0.005 CID_19100 | CID_19100 | |
| 0.229 | 0.173 | 0.5 | Histamine release inhibitor | 0.5 0.029 CID_154699531 | CID_154699531 | |
| 0.077 | 0.022 | 0.077 | Acetyl-CoA transferase inhibitor | |||
| 0.065 | 0.009 | 0.065 | Microtubule stabilization | 0.06 0.014 CID_19100 0.06 0.014 CID_154699531 | ||
| 0.077 | 0.022 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 CID_19100 0.062 0.033 CID_154699531 | ||
| 0.06 | 0.007 | 0.064 | Kainate receptor agonist | 0.064 0.005 CID_19100 | CID_19100 | |
| 0.086 | 0.034 | 0.086 | Leukotriene synthesis inhibitor | 0.076 0.04 CID_19100 | ||
| 0.06 | 0.007 | 0.06 | Delayed rectifier potassium channel blocker | 0.043 0.018 CID_19100 | ||
| 0.057 | 0.005 | 0.057 | Cholesterol ester transfer protein antagonist | 0.049 0.007 CID_19100 | ||
| 0.126 | 0.076 | 0.134 | NADPH oxidase inhibitor | 0.108 0.099 CID_19100 0.134 0.067 CID_154699531 | CID_154699531 | |
| 0.068 | 0.02 | 0.068 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.032 CID_19100 | ||
| 0.053 | 0.005 | 0.053 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.104 | 0.057 | 0.104 | Estrogen receptor beta antagonist | |||
| 0.114 | 0.067 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.144 0.048 CID_154699531 | CID_154699531 | |
| 0.075 | 0.029 | 0.075 | Biliverdin reductase inhibitor | 0.072 0.03 CID_19100 | ||
| 0.061 | 0.014 | 0.061 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.004 | 0.049 | Purinergic P2Y15 antagonist | 0.044 0.005 CID_19100 | ||
| 0.066 | 0.021 | 0.066 | Opioid mu receptor agonist | |||
| 0.063 | 0.019 | 0.063 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 CID_19100 | ||
| 0.053 | 0.01 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.052 0.01 CID_19100 | ||
| 0.105 | 0.062 | 0.159 | Toll-Like receptor 4 antagonist | 0.093 0.082 CID_19100 0.159 0.017 CID_154699531 | CID_154699531 | |
| 0.094 | 0.052 | 0.117 | Glutamate release inhibitor | 0.117 0.024 CID_154699531 | CID_154699531 | |
| 0.044 | 0.004 | 0.056 | Hedgehog signaling activator | 0.056 0.003 CID_19100 | CID_19100 | |
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | 0.037 0.031 CID_19100 | ||
| 0.086 | 0.046 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.101 | 0.063 | 0.118 | Bronchodilator | 0.118 0.046 CID_19100 | CID_19100 | |
| 0.079 | 0.04 | 0.079 | Opioid mu receptor antagonist | 0.068 0.047 CID_19100 | ||
| 0.057 | 0.019 | 0.103 | Mannosidase inhibitor | 0.062 0.015 CID_19100 0.103 0.005 CID_154699531 | CID_154699531 | |
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | 0.05 0.016 CID_19100 | ||
| 0.063 | 0.025 | 0.063 | Dihydroorotate oxidase inhibitor | 0.051 0.048 CID_19100 | ||
| 0.111 | 0.074 | 0.111 | Proteasome inhibitor | |||
| 0.062 | 0.024 | 0.069 | Aconitate hydratase inhibitor | 0.069 0.019 CID_19100 | CID_19100 | |
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | 0.078 0.044 CID_19100 | ||
| 0.046 | 0.009 | 0.073 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.073 0.005 CID_19100 0.042 0.01 CID_154699531 | CID_19100 | |
| 0.053 | 0.017 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 CID_19100 | ||
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | |||
| 0.042 | 0.006 | 0.091 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 CID_19100 0.091 0.003 CID_154699531 | CID_154699531 | |
| 0.058 | 0.022 | 0.058 | Squalene epoxidase inhibitor | 0.055 0.027 CID_19100 | ||
| 0.04 | 0.004 | 0.063 | Vanilloid 2 agonist | 0.037 0.005 CID_19100 0.063 0.002 CID_154699531 | CID_154699531 | |
| 0.053 | 0.018 | 0.057 | Guanylate cyclase inhibitor | 0.051 0.02 CID_19100 0.057 0.014 CID_154699531 | CID_154699531 | |
| 0.106 | 0.072 | 0.248 | Monophenol monooxygenase inhibitor | 0.248 0.024 CID_154699531 | CID_154699531 | |
| 0.045 | 0.011 | 0.045 | Prostaglandin agonist | 0.043 0.012 CID_19100 | ||
| 0.04 | 0.007 | 0.04 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.019 0.014 CID_19100 | ||
| 0.081 | 0.047 | 0.081 | Keratolytic | 0.07 0.065 CID_19100 | ||
| 0.183 | 0.15 | 0.183 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.055 | 0.022 | 0.055 | Adenylate cyclase 1 inhibitor | 0.055 0.021 CID_19100 | ||
| 0.102 | 0.069 | 0.102 | Ferrochelatase inhibitor | 0.096 0.075 CID_19100 | ||
| 0.05 | 0.018 | 0.05 | Retinoid X receptor agonist | |||
| 0.048 | 0.017 | 0.048 | Glutamate (mGluR group II) antagonist | 0.038 0.026 CID_19100 | ||
| 0.037 | 0.006 | 0.051 | Toll-Like receptor 4 agonist | 0.051 0.004 CID_154699531 | CID_154699531 | |
| 0.032 | 0.002 | 0.032 | Calcineurin inhibitor | 0.023 0.003 CID_19100 0.012 0.007 CID_154699531 | ||
| 0.129 | 0.101 | 0.311 | Anticoagulant | 0.311 0.027 CID_154699531 | CID_154699531 | |
| 0.038 | 0.009 | 0.038 | LFA antagonist | 0.036 0.01 CID_19100 | ||
| 0.042 | 0.016 | 0.042 | RNA-directed RNA polymerase stimulant | 0.039 0.017 CID_19100 | ||
| 0.029 | 0.004 | 0.029 | Nicotinic acid receptor 1 antagonist | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.02 CID_19100 | ||
| 0.034 | 0.01 | 0.082 | Sodium/glucose cotransporter 2 inhibitor | 0.039 0.009 CID_19100 0.082 0.004 CID_154699531 | CID_154699531 | |
| 0.034 | 0.011 | 0.034 | Prostaglandin EP2 agonist | 0.032 0.011 CID_19100 | ||
| 0.192 | 0.169 | 0.192 | Insulysin inhibitor | |||
| 0.093 | 0.07 | 0.093 | Aminopeptidase B inhibitor | 0.088 0.074 CID_19100 | ||
| 0.213 | 0.192 | 0.213 | GABA C receptor rho-3 antagonist | |||
| 0.037 | 0.016 | 0.037 | Prostaglandin EP3 antagonist | |||
| 0.025 | 0.004 | 0.025 | Thromboxane A2 agonist | 0.024 0.004 CID_19100 | ||
| 0.025 | 0.004 | 0.037 | Telomerase stimulant | 0.037 0.002 CID_19100 0.035 0.002 CID_154699531 | CID_19100 | |
| 0.057 | 0.036 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.061 | 0.042 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.041 CID_19100 | CID_19100 | |
| 0.039 | 0.019 | 0.047 | Fumarate hydratase inhibitor | 0.047 0.015 CID_19100 | CID_19100 | |
| 0.103 | 0.085 | 0.213 | Alkylator | 0.213 0.023 CID_154699531 | CID_154699531 | |
| 0.059 | 0.041 | 0.059 | Sphingosine kinase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 CID_19100 | ||
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_19100 | ||
| 0.022 | 0.005 | 0.023 | Vitamin D receptor agonist | 0.023 0.005 CID_19100 0.015 0.014 CID_154699531 | CID_19100 | |
| 0.033 | 0.016 | 0.033 | Glutamate (mGluR2) antagonist | 0.027 0.025 CID_19100 | ||
| 0.03 | 0.014 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.008 CID_154699531 | CID_154699531 | |
| 0.087 | 0.071 | 0.121 | ABCA1 expression enhancer | 0.121 0.03 CID_19100 | CID_19100 | |
| 0.071 | 0.055 | 0.071 | CDC25A inhibitor | |||
| 0.091 | 0.076 | 0.091 | Nitric-oxide synthase inhibitor | |||
| 0.019 | 0.004 | 0.019 | Thromboxane agonist | 0.014 0.005 CID_19100 | ||
| 0.023 | 0.009 | 0.023 | Progesterone receptor B antagonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | |||
| 0.043 | 0.029 | 0.043 | Histamine H2 receptor agonist | |||
| 0.02 | 0.007 | 0.036 | Antibiotic Macrolide-like | 0.018 0.008 CID_19100 0.036 0.004 CID_154699531 | CID_154699531 | |
| 0.028 | 0.015 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_19100 | CID_19100 | |
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 CID_19100 | ||
| 0.033 | 0.023 | 0.033 | Carboxypeptidase B inhibitor | |||
| 0.02 | 0.011 | 0.035 | Antibiotic Anthracycline-like | 0.02 0.01 CID_19100 0.035 0.003 CID_154699531 | CID_154699531 | |
| 0.111 | 0.103 | 0.28 | Lipid peroxidase inhibitor | 0.28 0.022 CID_154699531 | CID_154699531 | |
| 0.015 | 0.006 | 0.015 | Integrin beta2 antagonist | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.024 | 0.016 | 0.024 | Prostaglandin E2 agonist | 0.022 0.018 CID_19100 | ||
| 0.048 | 0.041 | 0.048 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 CID_19100 | ||
| 0.267 | 0.26 | 0.267 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.018 | 0.011 | 0.027 | Ileal bile acid transport inhibitor | 0.027 0.005 CID_154699531 | CID_154699531 | |
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.045 | 0.039 | 0.045 | Estrogen agonist | 0.044 0.039 CID_19100 0.043 0.04 CID_154699531 | ||
| 0.043 | 0.037 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.041 | 0.035 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Exportin-1 inhibitor | |||
| 0.135 | 0.13 | 0.135 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 CID_19100 | ||
| 0.039 | 0.034 | 0.039 | Sphingosine kinase 1 inhibitor | |||
| 0.057 | 0.053 | 0.065 | Nitric oxide donor | 0.065 0.041 CID_154699531 | CID_154699531 | |
| 0.056 | 0.053 | 0.386 | Selectin antagonist | 0.061 0.049 CID_19100 0.386 0.003 CID_154699531 | CID_154699531 | |
| 0.007 | 0.003 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 CID_19100 | CID_19100 | |
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | 0.011 0.009 CID_19100 | ||
| 0.07 | 0.067 | 0.07 | GABA B receptor agonist | |||
| 0.031 | 0.028 | 0.031 | ADAM10 endopeptidase inhibitor | |||
| 0.033 | 0.03 | 0.093 | Antibiotic Aminoglycoside-like | 0.035 0.026 CID_19100 0.093 0.003 CID_154699531 | CID_154699531 | |
| 0.058 | 0.055 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.02 | 0.017 | 0.022 | Corticosteroid-like | 0.021 0.015 CID_19100 0.022 0.013 CID_154699531 | CID_154699531 | |
| 0.057 | 0.054 | 0.057 | Purinergic P2X2 antagonist | |||
| 0.12 | 0.118 | 0.224 | Hexokinase inhibitor | 0.224 0.024 CID_19100 0.176 0.052 CID_154699531 | CID_19100 | |
| 0.066 | 0.064 | 0.066 | Phospholipase D inhibitor | |||
| 0.004 | 0.003 | 0.004 | Vitamin D-like | |||
| 0.045 | 0.044 | 0.061 | Cytokine production stimulant | 0.061 0.012 CID_154699531 | CID_154699531 | |
| 0.074 | 0.074 | 0.13 | Antineoplastic alkaloid | 0.13 0.034 CID_19100 | CID_19100 | |
| 0.113 | 0.114 | 0.224 | Diuretic | 0.224 0.036 CID_154699531 | CID_154699531 | |
| 0.014 | 0.016 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 CID_19100 | CID_19100 | |
| 0.088 | 0.091 | 0.093 | Hedgehog signaling inhibitor | 0.093 0.078 CID_19100 | CID_19100 | |
| 0.066 | 0.07 | 0.07 | GABA aminotransferase inhibitor | 0.07 0.062 CID_154699531 | CID_154699531 | |
| 0.027 | 0.033 | 0.037 | Progesterone antagonist | 0.037 0.024 CID_19100 | CID_19100 | |
| 0.033 | 0.039 | 0.04 | GABA uptake inhibitor | 0.04 0.027 CID_19100 | CID_19100 | |
| 0.018 | 0.028 | 0.075 | Protein 30S ribosomal subunit inhibitor | 0.075 0.004 CID_154699531 | CID_154699531 | |
| 0.025 | 0.037 | 0.057 | Arginase inhibitor | 0.057 0.011 CID_154699531 | CID_154699531 | |
| 0.017 | 0.032 | 0.028 | Estrogen receptor beta agonist | 0.028 0.024 CID_19100 | CID_19100 | |
| 0.045 | 0.061 | 0.114 | Heparanase inhibitor | 0.114 0.003 CID_154699531 | CID_154699531 | |
| 0.005 | 0.023 | 0.013 | Glucocorticoid agonist | 0.013 0.009 CID_19100 | CID_19100 | |
| 0.083 | 0.101 | 0.191 | AMP-activated protein kinase stimulant | 0.106 0.063 CID_19100 0.191 0.012 CID_154699531 | CID_154699531 | |
| 0.064 | 0.084 | 0.081 | Carbonic anhydrase VI inhibitor | 0.081 0.056 CID_19100 | CID_19100 | |
| 0.021 | 0.041 | 0.028 | Motilin receptor antagonist | 0.028 0.019 CID_154699531 | CID_154699531 | |
| 0.109 | 0.129 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 CID_154699531 | CID_154699531 | |
| 0.042 | 0.063 | 0.054 | Opioid delta receptor antagonist | 0.054 0.051 CID_19100 | CID_19100 | |
| 0.023 | 0.043 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 CID_19100 | CID_19100 | |
| 0.037 | 0.063 | 0.05 | Diacylglycerol O-acyltransferase inhibitor | 0.05 0.037 CID_19100 | CID_19100 | |
| 0.073 | 0.105 | 0.087 | Gastric antisecretory | 0.087 0.083 CID_19100 | CID_19100 | |
| 0.068 | 0.106 | 0.164 | Transcription factor NF kappa B stimulant | 0.102 0.037 CID_19100 0.164 0.013 CID_154699531 | CID_154699531 | |
| 0.107 | 0.147 | 0.303 | Hemostatic | 0.303 0.015 CID_154699531 | CID_154699531 | |
| 0.1 | 0.14 | 0.141 | Acetylcholine M1 receptor antagonist | 0.141 0.083 CID_19100 | CID_19100 | |
| 0.014 | 0.055 | 0.033 | Glucocorticoid antagonist | 0.033 0.022 CID_19100 | CID_19100 | |
| 0.014 | 0.054 | 0.042 | Motilin receptor agonist | 0.042 0.007 CID_154699531 | CID_154699531 | |
| 0.023 | 0.072 | 0.125 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.125 0.008 CID_19100 | CID_19100 | |
| 0.029 | 0.08 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.018 CID_154699531 | CID_154699531 | |
| 0.074 | 0.13 | 0.151 | Beta glucuronidase inhibitor | 0.151 0.024 CID_154699531 | CID_154699531 | |
| 0.177 | 0.237 | 0.417 | Antiobesity | 0.417 0.059 CID_19100 | CID_19100 | |
| 0.056 | 0.135 | 0.08 | Pim-3 kinase inhibitor | 0.08 0.076 CID_19100 | CID_19100 | |
| 0.161 | 0.253 | 0.372 | Alpha-glucosidase inhibitor | 0.372 0.126 CID_154699531 | CID_154699531 | |
| 0.067 | 0.164 | 0.118 | Bone formation stimulant | 0.118 0.087 CID_19100 | CID_19100 | |
| 0.031 | 0.151 | 0.078 | Neuraminidase (influenza) inhibitor | 0.078 0.027 CID_154699531 | CID_154699531 | |
| 0.02 | 0.149 | 0.071 | Neuraminidase inhibitor | 0.071 0.032 CID_154699531 | CID_154699531 | |
| 0.09 | 0.229 | 0.197 | Interleukin 6 antagonist | 0.197 0.043 CID_154699531 | CID_154699531 | |
| 0.027 | 0.167 | 0.082 | Glucose-6-phosphate translocase inhibitor | 0.082 0.01 CID_154699531 | CID_154699531 | |
| 0.015 | 0.182 | 0.072 | Liver X receptor agonist | 0.072 0.013 CID_19100 | CID_19100 | |
| 0.028 | 0.218 | 0.107 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.107 0.04 CID_19100 | CID_19100 | |
| 0.075 | 0.266 | 0.143 | DNA methylase inhibitor | 0.143 0.124 CID_154699531 | CID_154699531 | |
| 0.054 | 0.27 | 0.258 | Cell adhesion inhibitor | 0.258 0.014 CID_154699531 | CID_154699531 | |
| 0.031 | 0.257 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 CID_154699531 | CID_154699531 | |
| 0.067 | 0.345 | 0.134 | Tumour necrosis factor antagonist | 0.134 0.121 CID_19100 | CID_19100 | |
| 0.06 | 0.366 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 CID_154699531 | CID_154699531 | |
| 0.021 | 0.332 | 0.203 | Topoisomerase I inhibitor | 0.203 0.026 CID_154699531 | CID_154699531 | |
| 0.057 | 0.382 | 0.318 | Tumour necrosis factor alpha release inhibitor | 0.198 0.11 CID_19100 0.318 0.047 CID_154699531 | CID_154699531 | |
| 0.007 | 0.371 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 CID_19100 | CID_19100 | |
| 0.076 | 0.459 | 0.263 | Toll-Like receptor agonist | 0.263 0.137 CID_19100 | CID_19100 | |
| 0.006 | 0.391 | 0.038 | Liver X receptor antagonist | 0.038 0.015 CID_19100 | CID_19100 | |
| 0.02 | 0.438 | 0.107 | Cell adhesion molecule inhibitor | 0.107 0.03 CID_154699531 | CID_154699531 | |
| 0.018 | 0.449 | 0.22 | Topoisomerase II inhibitor | 0.22 0.029 CID_154699531 | CID_154699531 | |
| 0.063 | 0.509 | 0.267 | Toll-Like receptor 7 agonist | 0.267 0.133 CID_19100 | CID_19100 | |
| 0.077 | 0.589 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 CID_154699531 | CID_154699531 | |
| 0.015 | 0.547 | 0.089 | Factor IXa inhibitor | 0.089 0.013 CID_154699531 | CID_154699531 | |
| 0.016 | 0.551 | 0.087 | Uric acid excretion stimulant | 0.087 0.07 CID_154699531 | CID_154699531 | |
| 0.011 | 0.587 | 0.121 | Topoisomerase II alpha inhibitor | 0.121 0.029 CID_154699531 | CID_154699531 | |
| 0.016 | 0.818 | 0.182 | MAP3K9 inhibitor | 0.182 0.025 CID_19100 | CID_19100 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |